Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)
Learn more about:
Related Clinical Trial
TSC Biosample Repository and Natural History Database
Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy (TrustTSC OLE)
Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex
Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC
Feasibility of [11C]Acetate-Positron Emission Tomography (PET) in Lymphangioleiomyomatosis and Tuberous Sclerosis Complex
Lymphangioleiomyomatosis, a Study on Cathepsin K
Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy
KidneYou – Innovative Digital Therapy
Gait in Rare Diseases
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants
Doxycycline In Lymphangioleiomyomatosis (LAM)
Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
Turmeric as Treatment in Epilepsy
Study of the Disease Process of Lymphangioleiomyomatosis
RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM
The Effectiveness and Safety of Vagus Nerve Stimulation for TRE
The Effectiveness and Safety of Resective Epilepsy Surgery for TRE
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)
Safety of Simvastatin in LAM and TSC
Studies of Autistic Patients: Gene Networks and Clinical Subtypes
Topical Rapamycin to Erase Angiofibromas in TSC
Rapalogues for Autism Phenotype in TSC: A Feasibility Study
A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
Everolimus for Cancer With TSC1 or TSC2 Mutation
Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM
Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy – Tuberous Sclerosis Complex
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex
The Cognitive Variability in NF1 and TSC Monozygotic Twins
Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex
Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex
Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)
Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex
JASPER Early Intervention for Tuberous Sclerosis
Studies in Patients With Tuberous Sclerosis Complex
Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)
Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
Dermatologic Patterns of Tuberous Sclerosis Patients and Somatic Mutation Relationship
Genetic Heterogeneity and Genotype-phenotype Correlation of Children and Adults With Tuberous Sclerosis Complex (TuScCom)
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Tuberous Sclerosis Complex Natural History Study: Renal Manifestations
Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM
A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis
Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)
Study of Skin Tumors in Tuberous Sclerosis